Table 2.
Prevalence of disease comorbidity among study participants
| Variables | Totala N (%) |
Surgical site infection | (p-value) | ||
|---|---|---|---|---|---|
| Yes [n (%)] 53a | No [n (%)] 198a | ||||
| Cardiac disorder | |||||
| Yes | 20 (7.97) | 6 (11.32) | 14 (7.07) | 0.31 | |
| No | 231 (92.03) | 47 (88.68) | 184 (92.93) | ||
| Diabetes mellitus | |||||
| Yes | 6 (2.39) | 5 (9.43) | 1 (0.51) | < 0.001 | |
| No | 245 (97.61) | 48 (9.57) | 197 (99.49) | ||
| Malignancy | |||||
| Yes | 6 (2.39) | 2 (3.77) | 4 (2.02) | 0.45 | |
| No | 245 (97.61) | 51 (96.23) | 194 (97.98) | ||
| HIV/AIDS | |||||
| Yes | 4 (1.59) | 1 (1.89) | 3 (1.52) | 0.86 | |
| No | 247 (98.41) | 52 (98.11) | 195 (98.48) | ||
| Psychiatry problem | |||||
| Yes | 7 (2.79) | 3 (5.66) | 4 (2.02) | 0.15 | |
| No | 244 (97.21) | 50 (94.34) | 194 (97.98) | ||
| Respiratory disorder | |||||
| Yes | 7 (2.79) | 4 (7.55) | 3 (1.52) | 0.06 | |
| No | 244 (97.21) | 49 (92.45) | 195 (98.48) | ||
HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome
aPercentages are calculated from the number of a participant in each column